Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial
Lancet Infect Dis, v. 20, n. 7, p. 839-850, mar. 2020
Article
in En
| SES-SP, SESSP-IBPROD, SES-SP
| ID: bud-2991
Responsible library:
BR78.1
Full text:
1
Collection:
06-national
/
BR
Database:
SES-SP
/
SESSP-IBPROD
Type of study:
Clinical_trials
Country/Region as subject:
America do sul
/
Brasil
Language:
En
Journal:
Lancet Infect Dis
Year:
2020
Document type:
Article